Commentary
Article
AJMC® in the Press, September 5, 2025
Author(s):
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by SimplyWallSt referenced a study published online early ahead of the February 2026 issue of The American Journal of Managed Care® (AJMC®). The study, “Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients,” found that the type of ambulatory cardiac monitor can lead to a variation in clinical and economic outcomes in patients with commercial insurance.
An article from Newsbreak referenced a Q&A published on AJMC.com, the website of AJMC. The article, “Payer Education Is Key to Early DMD Therapy Access,” focused on how Duchenne muscular dystrophy can be more effectively treated when patient and providers have access to care and it is started in a timely manner.
An AJMC.com video interview, titled “Brensocatib’s Safety Profile Suggests Manageable AEs in Clinical Practice: James D. Chalmers, MBChB, PhD,” was referenced in an article from HealthCentral. The video interview featured James D. Chalmers, MBChB, PhD, speaking about how the use of brensocatib for bronchiectasis was safe and tolerable in patients after its approval by the FDA.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
